P e r -O t t o H a g e n , Phi), Durham, N.C., and Bergen, Norway Background: The development of intimal hyperplasia is a major cause of early vein graft failure. The study examines the effects of locally delivered antisense oligonucleotides to the proto-oncogene c-myb on the development of vein graft intimal hyperplasia.
March 1997 from 20% to 40% within 5 years depending on posi-tion3-8; however, recent evidence shows that up to 30% of grafts develop significant stenoses within 18 months. 911 Histologic examination of these early stenoses show intimal hyperplasia, thus making intimal hyperplasia a major obstacle to improved graft patency in this short-to medium-term period) Vein grafts in the short and long term have been shown to react differently to endothelial cell and smooth muscle cell vasoactive agonists, leading several authors to suggest that these changes may be markers of the particular phenotype that exists within the vessels)
A number of vascular smooth muscle mitogens whose expression is increased in proliferating vascular smooth muscle cells are believed to bind to a correspondingly large set of membrane-bound receptors, activating a series of intracellular secondary messengers, which in turn cause changes in gene expression) ,~2 The protein products that result from these changes in gene expression are responsible for smooth muscle cell behavior. Although it may be possible to inhibit the expression of individual mitogens, targeting key intracellular pathways common to many or all of these mitogens should theoretically be more successful in reducing or perhaps inhibiting smooth muscle cell proliferation. Proto-oncogenes are regulators of the cell cycle in that their protein products can act as transcription factors, binding to and activating the genes controlling cell turnover. 13, 14 Interference with the expression of these proto-oncogenes should therefore cause a reduction in cell proliferation. Antisense and other oligonucleotides, when coincubated with most cell types, are unstable because of rapid breakdown by serum nucleases) 5 Addition of a phosphorothioate backbone increases stability is without altering binding specificity. The antisense is believed to act by binding a target sequence of mRNA, thus either inhibiting progression and transportation out of the nucleus, rendering the mRNA susceptible for destruction by RNases, or preventing translation. 16 Simons et al. ~7 have reported a reduction in the development of intimal hyperplasia in a model of balloon-injured rat carotid artery with an antisense oligonucleotide to the proto-oncogene c-myb. By using a gel delivery system to deliver the c-myb antisense oligonucleotides to the outer surface of the balloon-injured artery, these investigators reduced the development of infimal hyperplasia to 15% that of control samples. The anfisense appeared to work at the level of DNA transcription, because these effects were accompanied by absence of detectable c-myb messenger RNA levels in the vascular smooth muscle cells. Villa et al. 18 in a similar model confirmed the activity and uptake of the oligonucleotides and localized the oligonucleotides to the medial smooth muscle cells within 24 hours of encasement.
Local gel delivery of an antisense oligonucleotide would appear to be an ideal treatment for vein bypass grafts, because their outer surface, unlike angioplas-• tied arteries, is exposed at the time of surgery. The thin wall of a venous conduit (two to three smooth muscle cell layers in the media) may also be more easily penetrated than the outer surface of an arterial segment, which has a thick smooth muscle cell layer in the media. This study therefore examines the effects of antisense c-myb oligonucleotide with a gel delivery system on vein graft intimal hyperplasia and vasomotor function, and defines the impact of this therapy on endothelial and smooth muscle cell phenotypes.
MATERIAL AND METHODS
Sixty male New Zealand White rabbits weighing 2.0 to 2.5 kg underwent right common carotid artery bypass grafting with reversed ipsilateral external jugular vein as previously described) 9 The animals were randomized to a control group or one of four treatment groups. Seventeen animals had only vein graft Surgery performed (control), 14 had their grafts coated with 2.5 ml of 30% F 127 Pluronic Gel (BASF, Parsiffany, N.J.) alone, 17 animals each had their grafts coated with gel containing antisense, and 6 animals each had their grafts coated with gel containing one of the other two oligonucleotides (sense or nonsense). Two hundred micrograms of each oligonucleotide was added to 2:5 ml of the gel delivery system and was delivered to the outer surface of the vein graft after the graft was complete and hemostasis was secured. The pluronic gel is reconstituted in aqueous solution at 4 ° C, at which point it is a liquid. On exposure to room temperature (20 ° C) the solution immediately forms a gel. After preparation the "gel solution" is kept on ice until administered to the graft. The gel has beenshown to clear from in vivo models in 1 to 2 hours, although oligonucleotide activity may be more prolonged. 17 In vitro studies have shown that the gel has released 90% of the olig0nucleotide by approximately 51 hours, with 100% release by 67 hours) 8 Three grafts each from the control and antisense-treated groups were harvested at 1 day for oligonucleotide uptake/localization analysis and at 3 days for mRNA extraction. The remaining grafts were harvested 28 days after surgery, and the animals were killed with an overdose of barbiturates. Animal care complied with the "Princi- Oligonucleotides. The oligonucleotides used were 18 bases in length and phosphorothioate-stabilized (Biosynthesis Inc, Lewisville, Tex.). The antisense used was identical to that used by Simons et al. 17 with the sequence GTGTCGGGGTCTC-CGGGC (position 4 to 22 of murine antisense). Two further oligonucleotides were used: sense GC-CCGGAGACCCCGACAC (identical to sequence of native myb DNA and complementary to the antisense in the 3'-5' direction) and a missense or nonsense sequenced comprising the 18 bases of the antisense but scrambled in a random fashion, GCCTGGGCT-GGCTGGTCG. This last sequence was to control for difference in base composition between the complementary sense and antisense. The rabbit c-myb sequence has recently been cloned and was unavailable when these experiments were performed. It differs from the murine c-myb by only one base, which occurs at position 15 (out of 18). One base pair mismatch has been shown not to significantly reduce oligonucleotide efficacy, especially when, as in this case, the mismatch is not at the end of the oligonucleotide.
Oligonucleotide uptake/localization analysis.
Fluorescein isothiocyanate-labeled antisense oligonucleotides were used to coat three vein grafts as described previously. Animals were killed after 24 hours, and the vein grafts were retrieved. Tissue localization and uptake were determined by placing freshly harvested vein graft segments in 4% paraformaldehyde for 3 hours. Specimens were then removed and cryoprotected in 30% sucrose with 0.1 mol/L phosphate buffer and frozen at 20 ° C. Frozen sections were visualized under fluorescence microscopy.
Northern analysis. Three control and antisense-treated 3-day vein grafts were harvested, snapfrozen in liquid nitrogen, and stored at -80 ° C until use. Total RNA was extracted from the vein grafts according to the procedure described by Chomczynski and Sacchi, 2° which is a single-step guaninidiumphenol-based extraction method using commercially available RNAzol solution (Biotecx, Houston, Texas). Poly A( + )-enriched mRNA was then purified from total RNA with an oligo-dT cellulose batchbinding and centrifugation protocol (Micro-Fast-Track, Invitrogcn Corp, San Diego, Calif.). For Northern blot analysis 5 Ixg mRNA from each sampie was denatured and fractionated on a 1% agarose/ formaldehyde gel and transferred to nylon membranes by capillary action overnight as previously described. 21 After transfer the blots were ultraviolet (UV) cross-linked and prehybridized at 42 ° C for 1 hour in Rapid-Hyb buffer (Amersham, Clearbrook, Ill.). Hybridization was then carried out overnight after the end-labeled (with [~/S2p] adenosine triphosphate and T4-Polynucleotide ldnase) antisense c-myb oligonucleotide was added. After hybridization was performed, blots were washed twice for 20 minutes in 55< SSC/0.1% sodium dodecyl sulfate (SDS) at room temperature and then in 1× SSC/0.1% SDS for 20 minutes at 42 ° C and exposed to x-ray film. For c-myb mRNA quantitation the blots were analyzed with a PhosphorImager (Molecular Dynamics, Sunnyvale, Calif.) to determine specific hybridization. To assess equal RNA loading the e-myb mRNA signals were normalized to the control transcript, glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
First, c-myb-probed blots were stripped in water at 100°C for 15 minutes and reprobed with a 32p. labeled rat GAPDH cDNA probe. After quantitation of the GAPDH signal was performed with a Phosphorlmager, the individual c-myb signals were normalized with the c-myb/GAPDH signal intensity ratio.
Morphologic studies. After isolation and heparinization (200 IU/kg intravenous) 10 grafts each from the control, gel, and antisense groups and 6 each from the sense and nonsense groups were perfusion-fixed in situ at 80 mm Hg as previously described. 19 After the graft was immersed in the fixative for 48 hours, cross-sections of the mid part of the graft were processed and stained with a modified Masson's trichrome and VerhoetPs elastin stain. 22 The lumen, intima, and media were defined and their dimensions (area, thickness, or both) calculated by videomorphometry (Innovision 150, American Innovision Inc., San Diego, Calif.). A ratio of the intima and media areas was calculated (intimal ratio = intimal area/[intimal + medial areas]). A ratio of the intimal and medial areas (intimal ratio = intimal area/[intimal + medial areas]) and a luminal diameter to cross-sectional wall thickness (luminal index = luminal diameter/[cross-sectional wall thickness]) was also calculated. For scanning electron microscopy mid-portion specimens of the glutaraldehyde-fixed grafts were rinsed with the same buffer solution as described previously, dehydrated in ascending concentrations of ethanol, transferred to absolute acetone, critical point-dried from CO2, March 1997 mounted on specimen stubs, and sputter-coated with gold-palladium according to standard techniques. All Specimens were examined in a Philips 500 scanning electron microscope (N.V. Philips, Eindhoven, The Netherlands) at an accelerating voltage of 12 or 20 kV. For transmission electron microscopy representative sections from the midportion of the glutaraldehyde-fixed grafts were postfixed tbr 1 hour at room temperature in 1% osmium-tetroxide dissolved in the same cacodylate buffer as used for the glutaraldehyde solution. After dehydration was performed in ascending concentrations of ethanol, the specimens were transferred to propylene oxide and finally embedded in an Epon 812 monomer: Polymerization was carried out overnight at 40 ° C followed by 2 days at 60 ° C. Ultrathin sections were cut with a diamond knife on a Reichart ultramicrotome (Reichart Optische Werke AG, Vienna, Austria), contrasted with uranyl acetate and lead citrate, and then examined in a Philips 300 transmission electron microscope (N.V. Philips, Eindhoven, The Netherlands), both operated at 60 kV.
Physiological studies. For isometric tension studies four vessels each from the control, gel, and gel with antisense groups were sectioned in situ into four 5-ram segments and excised, and each ring was immediately mounted between two stainless steel hooks in 5-ml organ baths containing oxygenated Norepinephrine (10 .9 to l0 -4 mol/L) was added cumulatively in half-molar increments, and the isometric tension developed by the vessel ring was measured as it contracted. After these additions were completed, the tissue was allowed to reequilibrate for a minimum of 30 minutes until it relaxed to its' original resting tension. Cumulative dose response curves to bradyldnin (10 -9 to 10 -s mol/L), histamine (I0 -9 to 10 -4 mol/L), and serotonin (10 -9 to I0 -4 mol/L) were then performed in a similar fashion with reequilibration after each dose response curve as before. After precontraction to 75% of maximum with norepinephrine, relaxation in response to cumulative doses of acetylcholine (10 .8 to 10 .4 mol/L) and sodium nitroprusside (10 .8 to 10 -4 mol/L) were also determined. All drugs were obtained from Sigma Chemical Co. (St Louis, Mo.).
Data and statistical analysis. The ECs0 value, the concentration for the half-maximal response, for each agonist in each ring was calculated by logistic analysis and is expressed as the pD2, which is defined as -logl0[ECs0]. 23 Emax (the maximal response expressed as a ratio of the contraction to 60 m m o l / L KCI) was also calculated. All data are presented as the mean _ SEM, and statistical differences among groups were tested by analysis of variance (ANOVA) with post hoc Tukey-Kramer multiple comparison tests for the functional studies and with a I(a'uskal-Wallis nonparametric ANOVA with post hoc Dunn's multiple comparison tests for the morphometric data. A p value less than 0.05 was regarded as significant.
RESULTS

Morphologic characteristics.
All animals survived to harvest, and all grafts were patent at harvest. On microscopic evaluation the luminal surfaces of the vein grafts from all five groups were covered by a layer of intact endothelial cells, bencath which lay a hyperplastic intima with the smooth muscle cells of the intimal hyperplasia arranged in a crisscross pattern with little extracellular matrix between (Fig. 1) . The medial smooth muscle cells in the grafts from all five groups appeared slender, were arranged in a circular pattern, and contained a greater amount of extracellular matrix suggestive of medial hypertro- phy. Dimensional analysis of the control and treatcd groups is shown in Table I . There was a 38% reduction in vein graft intimal thiclmess when the antisense/gel group was compared with both the control and gel alone groups (p < 0.01), On comparing intimal areas the antisense group was the only group in which there was a significant reduction (50%) compared with thc control group (p < 0.0i). These reductions were not seen with the other oligonuclcotidcs. There was no significant difference in either medial thickness or area when all groups were compared. The intimal ratio was reduced to significance in the antiscnse gel group only when compared with the control group (p > 0.03). Because one can argue that the true singlc control for the gcl/antiscnse is the gel with sensc or nonsense oligonuclcotide present, a secondary analysis of the data was performed that confirmed the findings of the primary data analysis. The intimal thickness was reduced (p < 0.01) without a change in medial thickness. The intimal ratio was decreased but failed to reach statistical significancc (p = 0.06, Table I ).
Scanning electron microscopy ofthc vascular surface of grafts from all groups showed that all grafts were covered by an uninterrupted layer of endothclial cells with well-defined borders. The endothelial cells of the control vein graft were characterized by their spindle-shaped outlines and numerous surface microprojections (Fig. 2, A) . In contrast, all the gel-treated grafts (with and without oligonucleotides) reveal a polygonal outline with almost complete absence of the surface microprojections (Fig. 2,  B and C) . The corresponding transmission electron micrographs confirmed the presence of an intact endothelial monolayer on the luminal surface of all grafts examined. All the vein grafts in this study showed evidence of both contractile and synthetic Smooth muscle cell phenotypes within their vessel walls. The subendothelium of the control vein graft was characterized by numerous layers of smoothmuscle cells lying on a well-organized connective tissue matrix (Fig. 3, A) . There was a predominance of contractile phenotypes in control grafts and synthetic phenotypes in all the treated grafts; these smooth muscle cells were predominantly of the contractile phenotype, having well-defined bundles of contractile material peripherally located within the cytoplasm. The subendothelium of grafts from the other four groups revealed a similar architecture; however, most smooth muscle cells were of the synthetic phenotype (cytoplasm containing a large amount of synthetic organelles) ( Fig. 3, B and C). The connective tissue of the intercellular spaces displayed a more chaotic pattern than did that of the control grafts.
Physiological studies. Vein grafts from the control, gel, and antisense groups responded in a concentration-dependent manner to norepinephrine, histamine, bradyldnin, and serotonin without a sig-nificant change in their respective sensitivities (Table  II) . The Emax for the vessels in the antisense group was unchanged for norepinephrine, histamine, and serotonin (Table II) but was decreased for bradykinin when compared with the control group (0.39 -+ 0.05 vs 0.84 + 0.08;/9 < 0.05). Precontracted vein grafts from the control group did not respond to ace@choline; however, 16 (67%) of the 24 graft: rings from the gel-only group did respond to ace@choline, relaxing to 59% + 7% ofprecontracted tension. In contrast to both the control and gel-treated vein grafts, all rings from the antisense group responded to acetylcholine, relaxing to 58% ± 9% of precontraction (Table II) . Grafts from all three groups responded in a concentration-dependent manner to sodium nitroprusside after precontracfion without any difference in sensitivity between groups (Table II) .
Oligonucleotide uptake/localization analysis. Fluorescein isothiocyanate-labeled antisense oligonucleotides were uniformly distributed within the media and adventitia by 1 day (Fig. 4) .
Northern blot analysis. Analysis of RNA from control and c-myb antisense-treated vein grafts harvested at 3 days showed no significant difference in c-myb mRNA expression between the two groups ( Fig. 5 ).
D I S C U S S I O N
Vascular smooth muscle cell mitogens are believed to bind membrane-bound receptors, triggering the activation of secondary messenger systems. These different cytosolic signals converge through activation and production of protein transcription factors, which in turn bind the DNA of genes that regulate the cell cycle, causing replication and cell division. 15 Biochemically active nuclear oncoproteins such as myb act as transcription factors, c-myb is a proto-oncogene that was originally thought present only in hemopoietic cells, 13 but it is now known to be present and to regulate the cell cycle in many cell types including vascular smooth muscle cells. 15 The myb protein is a sequence-specific DNA binding protein that binds to and activates promoter se- Beneath intact endothelium there is similar architecture to control grafts; however, most smooth muscle cells are of synthetic phenotype (i.e., cytoplasm contains large number of synthetic organelles). Connective tissue of intercellular spaces (*) display more chaotic pattern than that of control grafts. C, Transmission electron micrograph of graft treated with pluronic gel containing antisense c-myb oligonucleotide. Findings are similar to B with intact endothelial cell monolayer and subendothelium containing smooth muscle cells of predominantly synthetic phenotype.
quences on genes with the appropriate binding site and results in cell growth and proliferation. 13 c-myb expression increases from low baseline levels in quiescent cells to peak level when cells enter the late G 1 phase of the cell cycle. In proliferating cells, where the cell cycle moves directly from the G 1 phase to the S phase, peak levels occur at this G1/S interface, is Simons et al. 24 demonstrated that antisense c-myb oligonucleotide, when administered to cultured rat vascular smooth muscle cells, caused a reduction in cell proliferation of approximately 50% and that 4 hours of incubation with antisense produced the same degree ofantiproliferative activity as incubation for 72 hours. There was a marked reduction in c-myb messenger RNA levels, with levels approximately 25% that of cells incubated with sense c-myb oligonucleotide. Application of the antisense oligonucleotide to the external surface of a balloon-injured rat carotid artery with a gel delivery system produced similar resultsJ 7 Intimal thickness was reduced to 15% of sense control levels, with c-myb messenger RNA levels considerably reduced. Our results also showed a significant effect with a total 38% reduction in intimal thiclmess without producing changes in the dimensions of the media.
The antiproliferative effects of antisense oligonu--March 1997 cleotides have been attributed to direct inhibition of the mRNA of the relevant gene under investigation; however, the mechanism of action ofantisense 'oligonucleotides on cellular proliferation has recently come into question. 18,2~ Antisense oligonucleotides to the proto-oncogenes c-myb and c-myc have been shown to have a sequence of four consecutive guanosine (G) residues as part of their base construct. Other oligonucleotides containing this 4G sequence have been shown to have the same antiproliferative effect in smooth muscle cells in vitro. Burgess et al., 2s with growth-arrested cultured vascular smooth muscle cells, showed that the percentage of cells entering the S phase of the cell cycle is reduced when 4G base sequences are compared with non-4G sequences irrespective of whether the sequence is an antisense sequence. The "4G" effect does not, however, explain the ability of antisense technologies to inhibit smooth muscle cell proliferation in some in vivo studies. Villa et al.,~8 although showing a reduction in vascular smooth muscle cell proliferation in vitro with 4G sequences, failed to show any reduction on the development of intimal hypcrplasia in a model of balloon-injured rat common carotid artery with antisense and random sequence oligonucleotides containing 4G sequences when compared with the result obtained with a sense oligonucleotide that did not have a 4G sequence. In addition, Mann et al. 26 have shown a clear reduction in experimental vein graft intimal hyperplasia with liposome-aided uptake of antisense to proliferating cell nuclear antigen and cell division cycle 2 kinase (cdc2 kinase), neither of which contain a 4G sequence. More recendy, pluronic gel delivered antisense oligonucleotide to proliferating cell nuclear antigen, which lacks a 4G sequence, has been shown to be effective in reducing intimal hyperplasia. 27 The cumulative impact of these data suggest that the 4G theory cannot reasonably explain the findings reported in this study. In this study c-myb fluorescent oligonucleotides were evenly distributed throughout the media and adventitia of the vein within 24 hours, confirming earlier work by Villa et al) s c-myb mRNA was detected in all oligonucleotide grafts at 3 days; however, we could not demonstrate a decrease in the antisense-treated grafts. The presence of detectable c-myb expression suggests that there is a continued stimulus to smooth muscle cell proliferation. This finding would suggest that the single application of antiscnse may not be sufficient to fully control the proliferative response. This weakness of antisense technology has recently been highlightedY Alternatively, the dosage ofantisense chosen, although identical to that used to inhibit smooth muscle cell pro- liferation in the rat restenosis model, may not have been sufficient to completely inhibit the production of c-myb mRNA in the vein graft. Although mRNA levels in the antisense-treated grafts are unchanged from control levels, it is also possible that the mRNA may be antisense-bound and therefore detectable but nonfunctional. Finally, veins are exposed to very different hemodynamics on grafting into the arterial circulation, malting models of vein graft intimal hyperplasia different from balloon-injured arterial models. Vein grafts undergo continued remodeling as a result of the their continued exposure to a new hemodynamic environment. 29 This continued exposure partly explains the universal response of intimal hyperplasia in all veins after vein grafting. Antisense technology to inhibit intimal hyperplasia in vein grafts may lead to a different response than that obtained in balloon-injured arteries, which remain in their native circulation and neither experience a new and continued hemodynamic environment nor the trauma of harvest and implantation. 3°
The use of pluronic gel did not change graft dimensions when used in the non-antisense groups compared with the control group. There was, however, alteration in the ultrastructure of the grafts in all four groups treated with gel. All the vein grafts in this study showed evidence of both contractile and synthetic smooth muscle cell phenotypes within their vessel walls. A predominance of contractile phenotypes in control grafts and synthetic phenotypes was seen in all the treated grafts. These changes were also associated with a difference in the morphologic characteristics and the responsiveness of the overlying 1 2 3 4
Hg. 5. Representative Northern blot analysis of c-myb mRNA from 3-day control (lanes 1 and 2) and 3-day antisense oligonucleotide-treated (lanes 3 and 4) vein grafts. Messenger RNA was isolated from frozen samples, and approximately 5 ~g was electrophoresed, blotted, and hybridized with 32p-labeled c-myb antisense oligonucleotide as described in Methods. Specific hybridization to approximate 4kb c-myb mRNA was quantitated with a Phosphorlmager (Molecular Dynamics, Sunnyvale, Calif.) and normalized to specific hybridization of GAPDH mRNA following c-myb probe removal (Methods, data not shown). No significant differences in c-myb mRNA levels in 3-day antisense-treated vein grafts were observed. endothelial cells. Predominance of smooth muscle cells with a contractile phenotype is consistent with our result to date on the smooth muscle cell morphologic characteristics in the control vein graft at 28 days and has been found to reflect a steady mature state of the vein graft and its associated intimal hyperplasia. The presence of a predominance of smooth March 1997 muscle cells with a synthetic phenotype in the treated grafts is a common finding in any morphologic study of vein grafts that have been treated with a compound that has had an effect in reducing intimal hyperplasia. The presence of synthetic smooth muscle cells in the vein grafts would suggest that the vein graft is not in a steady state and may indicate either that there is still some ongoing smooth muscle proliferation or that the maturation process has been altered in these grafts, which in itself may contribute to the decrease in intimal" hyperplasia present. Irrespective of the changes in ultrastructural morphologic characteristics the vein graft smooth muscle cells did not show changes in their phenotype (i.e., there was no change in the response to the panel of contractile agents used).
Although vein grafts in the rabbit remain physiologically responsive conduits, acetylcholinc-mediated relaxation is lost after grafting, reflecting altered endothelial cell function. The preservation of receptormediated endothelium-dependent relaxation in each of the vein grafts is associated with a difference in the morphologic characteristics of the intimal surface observed on scanning electron microscopy. It is likely that the effects reflect two processes: one that is related to the pluronic gel (67% of specimens relaxed) and the second related to the present of the antisense oligonucleotides (100% of specimens relaxed). The effect of the pluronic gel-treated groups in preserving a degree of acetylcholine-mediated relaxation is unclear. The surfactant-based polymer may have some cell-protective effects caused by stabilization of the cell membranes. In addition, as a polyglycol the gel may confer some as yet uncharacterized antioxidant effects, which may reduce free radical formation, a process that is known to improve vein graft function in vein grafts. 31 The further preservation ofvasorelaxant response when the antisense oligonucleotide is added is unique and is not fully explicable given the known characteristics of the oligonucleotides. The degree of intimal hyperplasia reduction may partly contribute to this response, but a similar reduction in intimal hyperplasia has not been associated with similar preservation ofvasorelaxant response. In contrast to the changes in endothelial cell function, the response of the smooth muscle cells to a panel of contractile agonists was unchanged by either the presence of the gel alone or with added antisense. This absence of change occurred despite the decrease in the degree ofintimal hyperplasia and the apparent increase in the number of smooth muscle cells with synthetic phenotypes.
CONCLUSIONS
Locally delivered antisense oligonucleotides to proto-oncogene c-myb significantly reduces intimal hyperplasia with preservation of acetylcholine-mediated endothelium-dependent relaxation in experimental vein grafts. These findings suggests that targeting a common regulatory pathway of vascular smooth muscle mitogenesis can be successful in reducing the early development ofintimal hyperplasia. Pluronic gel can be used successfully as an oligonucleotide delivery system and may be particularly suited to vein grafts, because vein bypass grafting always allows access to the outer surface. The gel, with successful agent delivery and ease of application, may have major potential in the clinical setting.
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